Boston Scientific over the summer unveiled a new value-add for its implantable cardio devices: an online Trugevity calculator that lets physicians predict battery life.
The idea is to help health providers quickly grasp the benefits of Boston Sci’s longer lasting EnduraLife battery technology, which the company touts has nine clinical studies and eight years of real-world data to back up its abilities.
“We used to do those [battery life] calculations in-house … for physicians who are interested. … We decided, ‘Why not let the truth be free?’” said Ken Stein, SVP and CMO for rhythm management and global health policy at Boston Sci.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!